Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel Chan

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Clinical Transplantation|April 1, 2022
Critically important outcomes for infection in trials in kidney transplantation: An international survey of patients, caregivers, and health professionalsSamuel Chan, Martin Howell, David W Johnson, et al.
Kidney Medicine|August 31, 2023
Hospitalizations Among Adults With CKD in Public Renal Specialty Practices: A Retrospective Study From Queensland, AustraliaVishal Diwan, Wendy E Hoy, Zaimin Wang, et al.
Transplantation|March 3, 2021
Range and Consistency of Infection Outcomes Reported in Trials Conducted in Kidney Transplant Recipients: A Systematic ReviewSamuel Chan, Eric Au, David W Johnson, et al.
Nephrology (Carlton, Vic.)|September 26, 2022
Chronic kidney disease in public renal practices in Queensland, Australia, 2011-2018Wendy E Hoy, Zaimin Wang, Jianzhen Zhang, et al.
Transplantation|February 22, 2024
Report of the Standardized Outcomes in Nephrology-transplant Consensus Workshop on Establishing a Core Outcome Measure for Infection in Kidney Transplant RecipientsSamuel Chan, Rosanna Cazzolli, Allison Jaure, et al.
BMC Nephrology|March 20, 2026
Profiles and outcomes of indigenous patients with chronic kidney disease in renal speciality clinics in the public health system in Queensland, AustraliaWendy E Hoy, Vishal Diwan, Zaimin Wang, et al.
Journal for Immunotherapy of Cancer|February 17, 2022
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinationsAlessio Cortellini, Biagio Ricciuti, Victor R Vaz, et al.
Lung Cancer (Amsterdam, Netherlands)|July 29, 2024
Treatment patterns and outcomes in KRAS<sup>G12C</sup>-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort studySamir H Barghout, Luna Jia Zhan, Starvroula Raptis, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Clinical Transplantation|April 1, 2022
Critically important outcomes for infection in trials in kidney transplantation: An international survey of patients, caregivers, and health professionalsSamuel Chan, Martin Howell, David W Johnson, et al.
Kidney Medicine|August 31, 2023
Hospitalizations Among Adults With CKD in Public Renal Specialty Practices: A Retrospective Study From Queensland, AustraliaVishal Diwan, Wendy E Hoy, Zaimin Wang, et al.
Transplantation|March 3, 2021
Range and Consistency of Infection Outcomes Reported in Trials Conducted in Kidney Transplant Recipients: A Systematic ReviewSamuel Chan, Eric Au, David W Johnson, et al.
Nephrology (Carlton, Vic.)|September 26, 2022
Chronic kidney disease in public renal practices in Queensland, Australia, 2011-2018Wendy E Hoy, Zaimin Wang, Jianzhen Zhang, et al.
Transplantation|February 22, 2024
Report of the Standardized Outcomes in Nephrology-transplant Consensus Workshop on Establishing a Core Outcome Measure for Infection in Kidney Transplant RecipientsSamuel Chan, Rosanna Cazzolli, Allison Jaure, et al.
BMC Nephrology|March 20, 2026
Profiles and outcomes of indigenous patients with chronic kidney disease in renal speciality clinics in the public health system in Queensland, AustraliaWendy E Hoy, Vishal Diwan, Zaimin Wang, et al.
Journal for Immunotherapy of Cancer|February 17, 2022
Prognostic effect of body mass index in patients with advanced NSCLC treated with chemoimmunotherapy combinationsAlessio Cortellini, Biagio Ricciuti, Victor R Vaz, et al.
Lung Cancer (Amsterdam, Netherlands)|July 29, 2024
Treatment patterns and outcomes in KRAS<sup>G12C</sup>-positive advanced NSCLC patients previously treated with immune checkpoint inhibitors: A Canada-wide real-world, multi-center, retrospective cohort studySamir H Barghout, Luna Jia Zhan, Starvroula Raptis, et al.
Pageof 10